Supriya Lifescience Ltd

NSE: SUPRIYA · BSE: 543434 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹896.65
Market cap: ₹7,216 Cr
Revenue (annual): ₹827.9 Cr
Net profit (annual): ₹209.1 Cr
P/E (TTM): 36.4×Sector 47.4×
Promoter holding: 68.30%+0.00% QoQ
FII holding: 6.18%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Annual General Meeting 5 Other Announcement 3 Legal & Regulatory 3 Financial Results 3 Results Update 2 Dividend 2 Board Meeting Date 2 Results Correction 1 Regulatory Approval 1 Debt & Borrowing 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Apr 2026 15:05 IST BSE

Debt & Borrowing

Supriya Lifescience Debt & Borrowing

Supriya Lifescience Ltd informed exchanges that it does not qualify as a 'Large Corporate' per SEBI criteria for FY 2026-27. The company reported nil outstanding borrowings and an A+ credit rating from India Ratings. This disclosure confirms compliance with debt-market borrowing framework requirements.

Read the filing ↗